DocDollars

Saol Therapeutics Inc.

GA · United States · Reporting entity ID 100000151581

Total reported 2019–2025
$405K
#1,669 of 2,960 reporting companies — 0% of all reported industry payments
$255K in general payments across 1,452 records, plus $149K in research funding across 3 records.

How it breaks down

General payments $255,230
Research funding $149,448

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Saol Therapeutics Inc. reported $405K to US doctors and teaching hospitals from 2019 to 2025, ranking #1,669 of 2,960 reporting companies. 37% of that was research funding and 63% general payments such as consulting, speaking, food and travel. 1,452 general payment records and 3 research records were filed.

Common questions about Saol Therapeutics Inc.

How much has Saol Therapeutics Inc. paid US doctors?

Saol Therapeutics Inc. reported $404,677 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $255,230 in general payments, $149,448 in research funding.

How does Saol Therapeutics Inc. rank among drug and device companies?

It ranks #1,669 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Saol Therapeutics Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.